Trisha Wise-Draper, MD, PhD, recently began her new role as director of the IU School of Medicine Division of Hematology/Oncology. She’s also the cancer center’s inaugural deputy director and interim associate director of clinical research.
Before joining IU, she was a professor of medicine at the University of Cincinnati Cancer Center, section head of medical oncology, head and neck disease group leader, co-leader of the Head and Neck Experimental Advancement Laboratory (HEAL), and deputy director of the Office of Clinical Research. As a physician-scientist, she specializes in the care of patients with head and neck cancers and in experimental therapeutics.
Her research focuses on immunotherapy and precision oncology in head and neck cancer. Her work contributed to the design and execution of pivotal trials in this area, influenced the national standard of care, and built a collaborative translational research infrastructure that united a variety of teams for scientific excellence.
Nationally, she is the medical oncology vice chair for the NRG Oncology Head and Neck Cancer Committee and serves on the NCI Head and Neck Steering Committee. She is also senior editor of Clinical Cancer Research and section editor of JAHNS.
Her research funding portfolio includes NIH/NCI, American Cancer Society, Department of Defense, and industry support, with some grants exceeding $10 million. She has authored or co-authored more than 120 peer-reviewed publications.
In addition, she’s the Robert Wallace Miller Chair in Oncology, affectionately known as the “Robbie Chair.” The late V. Richard "Dick" Miller, a former Indiana senator, and his wife, Jane Miller, made the donation in honor of their son, Robert "Robbie" Wallace Miller, who succumbed to a rare form of cancer in 1976 at the age of 11. The Millers created the Robbie Chair at IU in 1995 and later established a second Robbie Chair at the Purdue Institute for Cancer Research in 2008.


